New oral drugs for multiple sclerosis.

New oral drugs for multiple sclerosis.

Item
http://www.wikidata.org/entity/Q37625921
Oestrogen receptor beta ligand: a novel treatment to enhance endogenous functional remyelination.Infection risk in patients on multiple sclerosis therapeutics.Oriental Medicine Samhwangsasim-tang Alleviates Experimental Autoimmune Encephalomyelitis by Suppressing Th1 Cell Responses and Upregulating Treg Cell Responses.Therapeutic strategies in childhood multiple sclerosisTherapeutic laquinimod treatment decreases inflammation, initiates axon remyelination, and improves motor deficit in a mouse model of multiple sclerosis.Treatment of multiple sclerosis in children and adolescents.Immunomodulatory drug treatment in multiple sclerosis.Pharmacogenomic update on multiple sclerosis: a focus on actual and new therapeutic strategies.Korean Red Ginseng and Ginsenoside-Rb1/-Rg1 Alleviate Experimental Autoimmune Encephalomyelitis by Suppressing Th1 and Th17 Cells and Upregulating Regulatory T Cells.
P2860

New oral drugs for multiple sclerosis.

Item
http://www.wikidata.org/entity/Q37625921
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
New oral drugs for multiple sclerosis.
@en
New oral drugs for multiple sclerosis.
@nl
type
label
New oral drugs for multiple sclerosis.
@en
New oral drugs for multiple sclerosis.
@nl
prefLabel
New oral drugs for multiple sclerosis.
@en
New oral drugs for multiple sclerosis.
@nl
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P478
P577
P698
P921
P356
P1433
P1476
New oral drugs for multiple sclerosis.
@en
P2093
P2860
P2888
P304
P31
P356
P478
P577
P698
P921